Laver, L. Et Al. 2024. The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma). KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY , vol.32, no.4 , 783-797.

Laver, L., Filardo, G., Sanchez, M., Magalon, J., Tischer, T., Abat, F., ... Bastos, R.(2024). The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma). KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY , vol.32, no.4, 783-797.

Laver, Lior Et Al. "The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma)," KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY , vol.32, no.4, 783-797, 2024

Laver, Lior Et Al. "The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma)." KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY , vol.32, no.4, pp.783-797, 2024

Laver, L. Et Al. (2024) . "The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma)." KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY , vol.32, no.4, pp.783-797.

@article{article, author={Lior Laver Et Al. }, title={The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma)}, journal={KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY}, year=2024, pages={783-797} }